Trial Profile
Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- Sponsors Allergan
- 10 Dec 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 09 Jul 2014 New trial record